about
New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships.Synthesis of a library of psi-stylostatins with potential antibacterial activity.Perspectives for clinical use of engineered human host defense antimicrobial peptidesQuinolone resistance in the food chain.Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative.Effects of a Mutation in the gyrA Gene on the Virulence of Uropathogenic Escherichia coli.Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii.Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.Antiadenovirus drug discovery: potential targets and evaluation methodologies.Clonal dissemination of Yersinia enterocolitica strains with various susceptibilities to nalidixic acid.Meningoencephalitis due to adenovirus in a healthy infant mimicking severe bacterial sepsis.Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates.Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis.Mechanism of binding of fluoroquinolones to the quinolone resistance-determining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance.Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.Impact of Pretransplant CMV-Specific T-cell Immune Response in the Control of CMV Infection after Solid Organ Transplantation: a prospective cohort studyPre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacinCharacterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolateInhibition of adenovirus infection by mifepristoneRepositioning salicylanilide anthelmintic drugs to treat adenovirus infectionsMultiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in BiomedicineStructure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus InfectionOptimization of piperazine-derived ureas privileged structures for effective antiadenovirus agentsT-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipientsDiscovery of niclosamide and its O-alkylamino-tethered derivatives as potent antibacterial agents against carbapenemase-producing and/or colistin resistant Enterobacteriaceae isolates
P50
Q31097310-126B063C-64B6-44F4-9BE0-ABFAF2B58173Q33435867-122DA834-9E9F-4068-85C8-E5506B7F88D3Q33700825-7B57B56E-D776-4A06-A93D-8B44284712B3Q34756640-0DD854C8-0E92-4799-8CC7-54669DE13751Q35183338-66D1F48F-6A7D-4C54-958C-F0814275852DQ35860017-1461E751-3F1B-43FB-9ECA-D207DB35C88EQ36424088-EB52676F-AFED-427D-8F50-5F6DCD55604AQ36746061-D378E340-04D5-43B9-ABAD-40F9D9470ECFQ38554369-22E879EF-D5EB-4C3E-8D53-51BF38089CFEQ39748421-53108C8C-80DD-4749-93ED-317AB3E8C638Q42231210-1DFBC225-2B72-44FF-AFB0-4FF37EDCE595Q42870899-C2B5E3E0-DDEC-4F07-A13B-A0FD5587A0E3Q43845127-41EEC2F5-1C04-4B92-8722-11277F19617FQ46094250-74CA99C9-8B61-4CF3-A0E9-020F35767123Q46447619-70C1C36E-6E35-479A-8524-6A4E0E0518B1Q54426692-8FDA33C0-E3E1-4F65-9F43-ED1195738222Q57186290-189596F4-6FF7-4617-B74F-FD86084E89F0Q58386917-24A266C3-146A-47F3-A8CE-29623AD60716Q58387109-5A823E8F-84E8-4FC3-A19B-40916F0C00F2Q59351576-08DF3B1D-AC4A-487A-8FB4-BC8AC9475770Q60915022-9F3A0230-6AB1-4C9B-9273-ADC53BC659EBQ64376900-81F508CE-B0BB-44F2-AFB7-B50E50ECA46CQ89654697-AF855F8D-08D2-4D38-9E63-67D066E8FCC6Q91230742-C215DC77-ED17-4510-B19D-CBBB15F25500Q92888793-C92705AE-E612-4584-98B0-04864A7B5DF4Q92895152-D7B2FB93-696F-41CF-935E-2873F7C9F72E
P50
description
researcher
@en
wetenschapper
@nl
name
Javier Sánchez-Céspedes
@en
Javier Sánchez-Céspedes
@nl
type
label
Javier Sánchez-Céspedes
@en
Javier Sánchez-Céspedes
@nl
prefLabel
Javier Sánchez-Céspedes
@en
Javier Sánchez-Céspedes
@nl
P106
P31
P496
0000-0003-2707-1979